These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9615862)

  • 41. Variola virus topoisomerase: DNA cleavage specificity and distribution of sites in Poxvirus genomes.
    Minkah N; Hwang Y; Perry K; Van Duyne GD; Hendrickson R; Lefkowitz EJ; Hannenhalli S; Bushman FD
    Virology; 2007 Aug; 365(1):60-9. PubMed ID: 17462694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase.
    Ahmed W; Sala C; Hegde SR; Jha RK; Cole ST; Nagaraja V
    PLoS Genet; 2017 May; 13(5):e1006754. PubMed ID: 28463980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of flexibility and long range communication on the function of human topoisomerase I.
    Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
    Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FOB1 affects DNA topoisomerase I in vivo cleavages in the enhancer region of the Saccharomyces cerevisiae ribosomal DNA locus.
    Di Felice F; Cioci F; Camilloni G
    Nucleic Acids Res; 2005; 33(19):6327-37. PubMed ID: 16269824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein:DNA interactions at chromosomal loop attachment sites.
    Blasquez VC; Sperry AO; Cockerill PN; Garrard WT
    Genome; 1989; 31(2):503-9. PubMed ID: 2561108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination.
    Bullock P; Champoux JJ; Botchan M
    Science; 1985 Nov; 230(4728):954-8. PubMed ID: 2997924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
    Meyer KN; Kjeldsen E; Straub T; Knudsen BR; Hickson ID; Kikuchi A; Kreipe H; Boege F
    J Cell Biol; 1997 Feb; 136(4):775-88. PubMed ID: 9049244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on DNA topoisomerase activity during in vitro chromatin assembly.
    Sekiguchi JA; Kmiec EB
    Mol Cell Biochem; 1988 Oct; 83(2):195-205. PubMed ID: 2849054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.
    Bonven BJ; Gocke E; Westergaard O
    Cell; 1985 Jun; 41(2):541-51. PubMed ID: 2985282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
    Beck WT; Danks MK
    Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule.
    Changela A; DiGate RJ; Mondragón A
    Nature; 2001 Jun; 411(6841):1077-81. PubMed ID: 11429611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure.
    Culotta V; Sollner-Webb B
    Cell; 1988 Feb; 52(4):585-97. PubMed ID: 2830030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New mechanistic and functional insights into DNA topoisomerases.
    Chen SH; Chan NL; Hsieh TS
    Annu Rev Biochem; 2013; 82():139-70. PubMed ID: 23495937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA topoisomerase i as a transcription protein and a lethal cellular toxin.
    Lotito L; Ferri F; Russo A; Capranico G
    Ital J Biochem; 2007 Jun; 56(2):122-9. PubMed ID: 17722653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.
    Cockerill PN; Garrard WT
    Cell; 1986 Jan; 44(2):273-82. PubMed ID: 3002631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy.
    Smith PJ
    Bioessays; 1990 Apr; 12(4):167-72. PubMed ID: 2159289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topoisomerase I in multiple drug resistance.
    Pessina A
    Cytotechnology; 1993; 12(1-3):127-35. PubMed ID: 7764454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
    Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
    Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.